Primal Kaur News Today

SAN DIEGO — A fragment antibody against thymic stromal lymphopoietin was safe and effective in reducing airway inflammation among patients with asthma, according to a presentation at the American Thoracic Society International Conference.“Thymic stromal lymphopoietin (TSLP) is involved in chronic inflammatory disorders, including asthma and COPD,” Maria Belvisi, PhD, senior vice

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that new Otezla (apremilast) data, along with findings on the unmet need for patients with plaque...